Figure 2.

The figure shows management strategy for patients with heart failure and CKD, including KRT. Adapted from the Kidney Disease Improving Global Outcomes Consensus Conference report (1). Stepwise, evidence-based drug therapy (increasing levels of evidence from the top to bottom of the pyramid) is shown in the middle. The bars on either side of the pyramid show relevant supportive treatment. AF, atrial fibrillation; ARNI, angiotensin receptor neprilysin inhibitor; CKD-MBD, CKD with mineral and bone disorder; CRRT, continuous KRT; i.v., intravenous; NSAID, nonsteroidal anti-inflammatory drug; RAASi, renin-angiotensin-aldosterone system inhibitor.